• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form POS AM filed by SOC Telemed Inc.

    4/6/22 2:36:00 PM ET
    $TLMD
    Managed Health Care
    Health Care
    Get the next $TLMD alert in real time by email
    POS AM 1 ea158067-posam_soctelemed.htm POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1

    As filed with the Securities and Exchange Commission on April 6, 2022

    Registration No. 333-258367

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    POST-EFFECTIVE AMENDMENT NO. 2

    TO FORM S-1 ON
    FORM S-3
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933

     

    SOC TELEMED, INC.

    (Exact Name of Registrant as Specified in Its Charter)

     

    Delaware   84-3131208
    (State or Other Jurisdiction of
    Incorporation or Organization)
      (I.R.S. Employer
    Identification Number)

     

    2411 Dulles Corner Park, Suite 475

    Herndon, Virginia 20171
    (866) 483-9690
    (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)

     

    Christopher M. Gallagher
    Chief Executive Officer

    SOC Telemed, Inc.

    2411 Dulles Corner Park, Suite 475

    Herndon, Virginia 20171

    (866) 483-9690

    (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)

     

    Copies to:

     

    Eunice J. Kim
    General Counsel

    SOC Telemed, Inc.
    2411 Dulles Corner Park, Suite 475
    Herndon, Virginia 20171
    (866) 483-9690

     

    Ryan K. Brissette
    Kirkland & Ellis LLP
    601 Lexington Avenue

    New York, NY 10022
    (212) 446 4934

     

    Approximate date of commencement of proposed sale to the public: Not applicable.

     

    If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐

     

    If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☐

     

    If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

     

    If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

     

    If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐

     

    If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

      Large accelerated filer ☐ Accelerated filer ☐
      Non-accelerated filer ☒ Smaller reporting company ☒
          Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     

     

     

    EXPLANATORY NOTE

     

    On August 2, 2021, SOC Telemed, Inc., a Delaware corporation (the “Registrant”), filed a Registration Statement on Form S-1 (the “Form S-1” and, as amended, the “Registration Statement”) (Registration No. 333-258367) with the U.S. Securities and Exchange Commission (the “Commission”), which was declared effective by the Commission on August 10, 2021. On December 7, 2021, the Registrant filed a Post-Effective Amendment No. 1 to Form S-1 on Form S-3, which was declared effective by the Commission on December 9, 2021, to convert the Form S-1 into a Registration Statement on Form S-3.

     

    On February 2, 2022, the Registrant entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Spark Parent, Inc., a Delaware corporation (“Parent”), and Spark Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent (“Merger Sub”). Pursuant to the Merger Agreement, effective April 6, 2022, Merger Sub merged with and into the Registrant, with the Registrant surviving the merger as a direct, wholly owned subsidiary of Parent.

     

    As a result of the completion of the transactions contemplated by the Merger Agreement, the Registrant has terminated any and all offerings of its securities pursuant to the Registration Statement. In accordance with an undertaking in the Registration Statement to remove from registration, by means of a post-effective amendment, any and all securities that were registered for issuance but remain unsold at the termination of the offering, the Registrant hereby removes from registration any and all securities of the Registrant registered but unsold under the Registration Statement as of the date hereof.

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, and Rule 478 thereunder, the Registrant has duly caused this Post-Effective Amendment No. 2 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Herndon, Commonwealth of Virginia, on April 6, 2022.

     

      SOC TELMED, INC.
       
      By: /s/ Christopher M. Gallagher
        Christopher M. Gallagher
        Chief Executive Officer

     

     

    2

     

     

    Get the next $TLMD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TLMD

    DatePrice TargetRatingAnalyst
    4/1/2022$3.00Neutral
    Credit Suisse
    2/7/2022$2.00 → $3.00Neutral
    Credit Suisse
    2/4/2022Buy → Hold
    Benchmark
    2/3/2022$6.00 → $3.00Outperform → Sector Perform
    RBC Capital
    2/3/2022$4.00 → $3.00Outperform → Neutral
    Baird
    1/7/2022$6.00 → $2.00Outperform → Neutral
    Credit Suisse
    8/13/2021$10.00 → $6.00Outperform
    RBC Capital
    8/13/2021$11.00 → $8.50Outperform
    Credit Suisse
    More analyst ratings

    $TLMD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Securonix Appoints Eunice Kim as General Counsel

      Veteran Legal Executive Brings More Than Two Decades of Experience in Private and Public Sector Regulatory Affairs, Ethics and Compliance to Unified Defense SIEM Leader Securonix, Inc., a leader in Unified Defense SIEM, today announced the appointment of Eunice Kim as general counsel. In this role, Kim will be responsible for leading Securonix's legal and compliance functions, enhancing processes for evaluating expansion and growth opportunities, and implementing corporate policies that support the company's mission, vision and values. "Eunice is a dynamic legal executive, and we are thrilled to welcome her to Securonix," said Nayaki Nayyar, Chief Executive Officer, Securonix. "Her prov

      11/30/23 10:00:00 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • SOC Telemed Completes Acquisition by Patient Square Capital

      HERNDON, Va., April 6, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced the completion of its previously announced transaction to be acquired by Patient Square Capital, a leading dedicated health care investment firm, in an all-cash transaction. The acquisition was previously announced on February 3, 2022, and SOC Telemed's stockholders approved the transaction at the Special Meeting of Stockholders held on April 4, 2022. Upon completion of the acquisition, SOC Telemed stockholders received $3.00 in cash per share of Class A common stock. SOC Telemed's Class A common stock and warr

      4/6/22 7:45:00 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • SOC Telemed Stockholders Approve Acquisition by Patient Square Capital

      HERNDON, Va., April 4, 2022 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD) (the "Company" or "SOC Telemed"), the largest national provider of acute care telemedicine, today announced that its stockholders approved the acquisition of SOC Telemed by Patient Square Capital, a leading dedicated health care investment firm, at a special meeting. Steve Shulman, Chairman of the SOC Telemed Board of Directors, said, "On behalf of the SOC Telemed Board, I would like to thank our stockholders for their support of this transaction. Today's vote represents an important milestone towards

      4/4/22 4:18:00 PM ET
      $TLMD
      Managed Health Care
      Health Care

    $TLMD
    SEC Filings

    See more
    • SEC Form 15-12B filed by SOC Telemed Inc.

      15-12B - SOC Telemed, Inc. (0001791091) (Filer)

      4/18/22 7:00:34 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • SEC Form EFFECT filed by SOC Telemed Inc.

      EFFECT - SOC Telemed, Inc. (0001791091) (Filer)

      4/11/22 12:15:22 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • SEC Form EFFECT filed by SOC Telemed Inc.

      EFFECT - SOC Telemed, Inc. (0001791091) (Filer)

      4/11/22 12:15:28 AM ET
      $TLMD
      Managed Health Care
      Health Care

    $TLMD
    Leadership Updates

    Live Leadership Updates

    See more
    • Anne McGeorge, Former Managing Partner of Grant Thornton LLP, Joins CitiusTech’s Board of Directors and Chair of the Audit Committee

      PRINCETON, N.J.--(BUSINESS WIRE)--CitiusTech, a leading provider of healthcare technology services and solutions, announced today that Anne McGeorge, former Managing Partner of Grant Thornton’s Global Health Care and Life Sciences Practices, has joined its Board of Directors and chair of the Audit Committee. Ms. McGeorge comes with over 35 years of experience advising healthcare clients in all aspects of finance and transformational change, including strategy, M&A, joint ventures, financial statement audits, corporate restructuring, governance, talent acquisition, executive compensation, IRS matters and risk management. She created the healthcare / life sciences practice for Gran

      1/12/21 9:07:00 AM ET
      $TLMD
      $MGTA
      Managed Health Care
      Health Care
      Biotechnology: Pharmaceutical Preparations

    $TLMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Warburg Pincus & Co. returned $101,624,895 worth of shares to the company (33,874,965 units at $3.00)

      4 - SOC Telemed, Inc. (0001791091) (Issuer)

      4/7/22 4:45:23 PM ET
      $TLMD
      Managed Health Care
      Health Care
    • SEC Form 4: Warburg Pincus & Co. returned $101,624,895 worth of shares to the company (33,874,965 units at $3.00)

      4 - SOC Telemed, Inc. (0001791091) (Issuer)

      4/7/22 4:44:31 PM ET
      $TLMD
      Managed Health Care
      Health Care
    • SEC Form 4: Shulman Steven J returned $3,336,873 worth of shares to the company (1,112,291 units at $3.00), closing all direct ownership in the company (tax liability)

      4 - SOC Telemed, Inc. (0001791091) (Issuer)

      4/7/22 4:29:25 PM ET
      $TLMD
      Managed Health Care
      Health Care

    $TLMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Credit Suisse resumed coverage on SOC Telemed with a new price target

      Credit Suisse resumed coverage of SOC Telemed with a rating of Neutral and set a new price target of $3.00

      4/1/22 7:17:19 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • Credit Suisse reiterated coverage on SOC Telemed with a new price target

      Credit Suisse reiterated coverage of SOC Telemed with a rating of Neutral and set a new price target of $3.00 from $2.00 previously

      2/7/22 8:24:46 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • SOC Telemed downgraded by Benchmark

      Benchmark downgraded SOC Telemed from Buy to Hold

      2/4/22 6:36:59 AM ET
      $TLMD
      Managed Health Care
      Health Care

    $TLMD
    Financials

    Live finance-specific insights

    See more
    • SOC Telemed Reports Third Quarter 2021 Financial and Operating Results

      RESTON, Va., Nov. 12, 2021 /PRNewswire/ -- SOC Telemed, Inc., (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced its financial and operating results for the third quarter ending September 30, 2021. SOC Telemed Reports Third Quarter 2021 Financial and Operating Results "We are proud of our third quarter results as the new organization came together with renewed focus resulting in the highest quarterly revenue and bookings in our company's history," said Dr. Chris Gallagher, Chief Executive Officer. "Upon joining the Company, my first task h

      11/12/21 7:00:00 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • SOC Telemed to Provide Corporate and Financial Update for the Third Quarter 2021 on November 12, 2021

      RESTON, Va., Oct. 29, 2021 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced that the company will provide a corporate and financial update for the third quarter 2021, on Friday, November 12, 2021, before market open. SOC Telemed's management team will host a conference call and live audio webcast at 8:00 a.m. ET. To participate in the call, dial either the domestic or international number or join the webcast from your computer or mobile phone. Domestic: (877) 292-0959 International: (412) 542-4143 Passco

      10/29/21 7:00:00 AM ET
      $TLMD
      Managed Health Care
      Health Care
    • SOC Telemed Announces Introductory Conference Call with New Leadership

      RESTON, Va., Sept. 7, 2021 /PRNewswire/ -- SOC Telemed, Inc. (NASDAQ:TLMD), the largest national provider of acute care telemedicine, today announced that the Company will host an introductory conference call with new leadership, which was announced on September 1, 2021. Dr. Chris Gallagher, CEO of the Company, and Joe Greskoviak, Vice Chairman of the Board of Directors, will host the call on Thursday, September 9, 2021, at 5 p.m. ET. Dial-In Numbers Domestic: (877) 292-0959 International: (412) 542-4143 Passcode: please ask to join the SOC Telemed call A live audio webcast w

      9/7/21 4:05:00 PM ET
      $TLMD
      Managed Health Care
      Health Care

    $TLMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by SOC Telemed Inc. (Amendment)

      SC 13D/A - SOC Telemed, Inc. (0001791091) (Subject)

      4/7/22 4:47:02 PM ET
      $TLMD
      Managed Health Care
      Health Care
    • SEC Form SC 13G filed by SOC Telemed Inc.

      SC 13G - SOC Telemed, Inc. (0001791091) (Subject)

      3/24/22 4:10:01 PM ET
      $TLMD
      Managed Health Care
      Health Care
    • SEC Form SC 13G/A filed by SOC Telemed Inc. (Amendment)

      SC 13G/A - SOC Telemed, Inc. (0001791091) (Subject)

      2/14/22 3:54:05 PM ET
      $TLMD
      Managed Health Care
      Health Care